The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of increased use of adjuvant chemotherapy in non-small cell lung cancer: A population and economic assessment.
J. R. Goffin
No relevant relationships to disclose
W. Flanagan
Employment or Leadership Position - Statistics Canada
C. Earle
No relevant relationships to disclose
J. Hoch
No relevant relationships to disclose
K. Asakawa
Employment or Leadership Position - Statistics Canada
N. Mittmann
No relevant relationships to disclose
M. Wolfson
No relevant relationships to disclose
W. K. Evans
No relevant relationships to disclose